Video from the Webinar “Risk-based Monitoring for Clinical Research Leaders”

The new Risk-based Monitoring concept reforms the clinical monitoring and clinical trial management. Risk factors become an important component there.

What does it mean for a pharmaceutical company? Clinical trial risks are easy to foresee, site level risks and operational risks are hard to detect.

In this compact webinar, a clinical research leader can find answers how to turn the new risk management approach to your best. What to start with and how to avoid other risks, connected with the implementation of this concept.

By |2016-12-20T19:48:09+00:00December 20, 2016|Blog|0 Comments

About the Author:

Professional in the integration of data-driven Risk-based Monitoring (RbM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, PharmaForum, PharmaDay, DGGF, etc. 10+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RbM research to new frontiers for CROs, pharma and biotech companies.

Leave A Comment

Upcoming Events

  1. DIA Europe 2019

    February 5 - February 7

Register Today!

Get Free Test Access